Herring and Olive Oil Blend for Atherosclerosis Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current dietary supplements, including omega-3 fatty acids, have shown limited effectiveness in preventing and treating coronary heart disease, thrombosis, and inflammatory diseases such as psoriasis and rheumatoid arthritis, as they often fail to adequately reduce monocyte reactivity and production of pro-inflammatory products, and may even exacerbate conditions like angina and occlusions.
Innovation Solution
A combination of 33% herring oil, 33% cold-pressed virgin olive oil, and 33% omega-3 fatty acids enriched in DHA, EPA, and DPA, which synergistically reduces atherosclerosis, inflammatory responses, and oxidative metabolites, providing enhanced antioxidation effects and improved storage stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If omega-3 fatty acid supplements are used to prevent coronary heart disease, then cardiovascular protection is intended, but they may exacerbate conditions like angina and occlusions and fail to adequately reduce monocyte reactivity
Solution Approach 1:
The patent combines herring oil (containing omega-3 fatty acids EPA and DHA) with cold-pressed virgin olive oil in a 1:1 ratio. This merging of two different oil sources creates a synergistic effect where the olive oil components help modulate the inflammatory response while the herring oil provides cardiovascular protective omega-3 fatty acids, thereby reducing monocyte reactivity while maintaining cardiovascular benefits
Solution Approach 2:
The invention creates a composite oil product combining marine oil (herring oil) and vegetable oil (olive oil) with specific fatty acid profiles. This composite material approach allows the product to deliver both the cardiovascular protection of omega-3s and the anti-inflammatory properties of olive oil components, effectively addressing both the beneficial and harmful effects
2Reliability
If omega-3 fatty acids are supplemented to reduce atherosclerosis, then cardiovascular protection is intended, but they show limited effectiveness in reducing atherosclerotic lesions
Solution Approach 1:
The patent merges herring oil rich in omega-3 fatty acids with cold-pressed virgin olive oil containing anti-atherogenic compounds. This combination produces a synergistic effect that significantly reduces atherosclerotic lesion formation (49% reduction in mice studies), far exceeding the effectiveness of omega-3 supplementation alone
Solution Approach 2:
The invention changes the compositional parameters by specifying exact ratios (33% herring oil, 33% olive oil, 33% omega-3 concentrate) and fatty acid profiles. This precise parameter control optimizes the anti-atherosclerotic effect, achieving 72.9% reduction in liver lipids and 49% reduction in atherosclerotic lesions
3Reliability
If omega-3 fatty acid supplements are used to treat inflammatory diseases, then anti-inflammatory effect is intended, but they fail to adequately reduce production of pro-inflammatory products
Solution Approach 1:
The patent combines herring oil with cold-pressed virgin olive oil, where the olive oil components work synergistically to reduce the production of pro-inflammatory cytokines and oxidative metabolites. This merging creates a product that effectively treats inflammatory diseases by addressing both the inflammatory response and the harmful product generation
Solution Approach 2:
The invention converts the potential harmful effect of omega-3 fatty acids (which can sometimes increase inflammation in certain conditions) into a benefit by combining them with olive oil components that modulate the inflammatory response. This transforms the harmful pro-inflammatory potential into a beneficial anti-inflammatory effect
Data Source
AI summary
A combination of oils as a supplement to, or component of, a regular diet, wherein it comprises marine oil, preferably herring oil, and cold-pressed virgin olive oil.